Petri Dish RSS

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

The assistance of AI-based computer-aided detection for mammogram screenings did not impact recall rates in a radiologist’s standard single reading.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO

Handling an Intricate Case of R/R MM With BCMA/GPRC5D Bispecific Antibodies

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

A cancer care team contemplated the methods and reasoning for handling a complex case of heavily pretreated relapsed or refractory multiple myeloma.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;David Morris, MD, MS;Tanya B. Dorff, MD;Mark T. Fleming, MD

March 5th 2025

Clinicians Consider Identification, Management of RCC Through the Patient’s Eyes

A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.

March 8th 2025

Durvalumab Combo Meaningfully Improves EFS in Advanced Gastric/GEJ Cancer

James Zoeller discussed various aspects of his cancer care after a RCC diagnosis with Hannah D. McManus, MD, and Allison Brown, BSN, RN, RN-BC.

Data from the MATTERHORN trial show a trend towards improved overall survival with the durvalumab combination in gastric and GEJ cancers.

Russ Conroy

AI-Assisted Mammography Screenings Show Preliminary Detection Improvement

Data from the MATTERHORN trial show a trend towards improved overall survival with the durvalumab combination in gastric and GEJ cancers.

Related Content

Roman Fabbricatore

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

The assistance of AI-based computer-aided detection for mammogram screenings did not impact recall rates in a radiologist’s standard single reading.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO

Handling an Intricate Case of R/R MM With BCMA/GPRC5D Bispecific Antibodies

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

A cancer care team contemplated the methods and reasoning for handling a complex case of heavily pretreated relapsed or refractory multiple myeloma.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;David Morris, MD, MS;Tanya B. Dorff, MD;Mark T. Fleming, MD

March 5th 2025

Clinicians Consider Identification, Management of RCC Through the Patient’s Eyes

A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.

March 8th 2025

Durvalumab Combo Meaningfully Improves EFS in Advanced Gastric/GEJ Cancer

James Zoeller discussed various aspects of his cancer care after a RCC diagnosis with Hannah D. McManus, MD, and Allison Brown, BSN, RN, RN-BC.

Russ Conroy